# US 2014/0155278 A1 · System and method for detecting biological materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0155278 A1
- Document ID: US20140155278A1
- Status: Published application
- Kind: A1
- Application number: 13/971,498
- Filed: 2013-08-20
- Published: 2014-06-05
- Earliest claimed: 2012-08-21
- Assignees: Industrial Technology Research Institute
- Applicants: Industrial Technology Research Institute
- Inventors: Yi-Chang Chen; Jane SC Tsai
- Web page: https://patentgrep.com/patent/US20140155278A1

## CPC

- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/682: Signal amplification
- G01N 33/54333: {Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction}
- C12Q 1/6813: Hybridisation assays
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C40B 20/04: Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

A method of identifying a target biological material by using captures and probes. Each capture is specific for a kind of target. Each probe is designed to distinguish the type of the target. The captures and probes are each labeled with one or more detectable labels.

## Claims

### Claim 1

A method of identifying a biological material, the method comprising:
providing a sample containing a biological material, wherein the biological material has a kind and a type;
adding to the sample one or more captures and one or more probes, each capture and each probe being labeled with one or more detectable labels, wherein each capture is specific for a kind of biological material and each probe is specific for a type of biological material, and the one or more captures are distinguishable from each other by their detectable labels and the one or more probes are distinguishable from each other by their detectable labels, whereby a combination of detectable labels identifies a kind and a type of the biological material;
allowing the one or more captures and the one or more probes to bind to the biological material; and
determining the detectable labels bound to the biological material, whereby the kind and the type of the biological material are identified.

### Claim 2 (depends on 1)

The method of claim 1, wherein the detectable labels are colored labels.

### Claim 3 (depends on 2)

The method of claim 2, wherein the one or more captures include a total of n different colored labels and the one or more probes include a total of m different colored labels, n and m each being an integer that is 1 or greater.

### Claim 4 (depends on 1)

The method of claim 1, wherein the sample is a blood sample, a serum sample, a plasma sample, an urine sample, a saliva sample, a tissue sample, a cell sample, a sample containing amplified nucleic acids, or a sample containing a purified or partially purified biological material.

### Claim 5 (depends on 1)

The method of claim 1, wherein the biological material is a nucleic acid molecule, a tissue, or an organism.

### Claim 6 (depends on 1)

The method of claim 1, wherein the kind is a specific gene or species of an organism.

### Claim 7 (depends on 1)

The method of claim 1, wherein the type is genotype, a single nucleotide polymorphism (SNP) or a combination of SNPs, a mutation or a combination of mutations, a nucleic acid sequence, or a type or subtype of a species of organism.

### Claim 8 (depends on 2)

The method of claim 2, wherein each of the colored labels is detectable with visible light, fluorescence, luminescence, LED light, UV light, laser, or a combination thereof.

### Claim 9 (depends on 3)

The method of claim 3, wherein the one or more captures and the one or more of probes share x colored labels, wherein x is an integer that is equal to or greater than 0 and less than n+m.

### Claim 10 (depends on 9)

The method of claim 9, wherein the determining step is conducted by imaging each colored label individually to obtain n+m−x individual images.

### Claim 11 (depends on 1)

The method of claim 1, wherein each capture contains a small solid particle that is labeled with one or more detectable labels.

### Claim 12

A method of identifying one or more target nucleic acids, the method comprising:
providing a sample containing nucleic acid molecules;
mixing the sample with one or more captures and one or more probes to obtain a mixture, wherein (i) each capture is labeled with one or more detectable labels such that it is distinguishable from the other captures by its detectable labels, and contains a capture nucleic acid sequence complementary to a first target sequence in a target nucleic acid, and (ii) each probe is labeled with one or more detectable labels such that it is distinguishable from the other probes by its detectable labels, and contains a probe sequence that is complementary to a second target sequence in a target nucleic acid, whereby a combination of detectable labels identifies a target nucleic acid molecule;
allowing the one or more captures and the one or more probes to hybridize to the nucleic acid molecules, thereby complexes each containing a target nucleic acid, a capture, and a probe are formed; and
determining the detectable labels bound to the complexes, whereby one or more target nucleic acids are identified.

### Claim 13 (depends on 12)

The method of claim 12, wherein the detectable labels are colored labels.

### Claim 14 (depends on 12)

The method of claim 12, wherein each probe is specific for one or more SNPs or one or more mutations in a second target sequence.

### Claim 15 (depends on 13)

The method of claim 13, wherein the one or more captures include a total of n different colors and the one or more probes include a total of m different colors, n and m each being an integer that is 1 or greater.

### Claim 16 (depends on 15)

The method of claim 15, wherein the one or more captures and the one or more probes share x colored labels, wherein x is an integer that is equal to or greater than 0 and less than n+m.

### Claim 17 (depends on 16)

The method of claim 16, wherein the determining step is conducted by imaging each colored label individually to obtain n+m−x individual images

### Claim 18 (depends on 13)

The method of claim 13, wherein each of the colored labels is detectable with visible light, fluorescence, luminescence, LED light, UV light, laser, or a combination thereof.

### Claim 19 (depends on 11)

The method of claim 11, wherein the target nucleic acids include the vitamin K epoxide reductase gene or a fragment thereof and the cytochrome p450 gene or a fragment thereof, and the SNPs include SNPs associated with warfarin sensitivity.

### Claim 20 (depends on 11)

The method of claim 11, wherein each capture contains a small solid particle that is labeled with one or more detectable labels.

### Claim 21 (depends on 11)

The method of claim 11, wherein the hybridization step is carried out in an emulsion.

### Claim 22 (depends on 11)

The method of claim 11, wherein the mixture further contains a lysis buffer, primers for amplifying a target nucleic acid, and PCR reagents, and the method further comprises conducting PCR on the mixture prior to the hybridization step.

### Claim 23 (depends on 22)

The method of claim 22, wherein the mixing step, the PCR step, and the hybridization step are conducted in the same container.
